Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype

Pullinger, Clive R.; Eng, Celeste; Salen, Gerald; Shefer, Sarah; Batta, Ashok K.; Erickson, Sandra K.; Verhagen, Andrea; Rivera, Christopher R.; Mulvihill, Sean J.; Malloy, Mary J.; Kane, John P.
July 2002
Journal of Clinical Investigation;7/1/2002, Vol. 110 Issue 1, p109
Academic Journal
journal article
Bile acid synthesis plays a critical role in the maintenance of mammalian cholesterol homeostasis. The CYP7A1 gene encodes the enzyme cholesterol 7alpha-hydroxylase, which catalyzes the initial step in cholesterol catabolism and bile acid synthesis. We report here a new metabolic disorder presenting with hyperlipidemia caused by a homozygous deletion mutation in CYP7A1. The mutation leads to a frameshift (L413fsX414) that results in loss of the active site and enzyme function. High levels of LDL cholesterol were seen in three homozygous subjects. Analysis of a liver biopsy and stool from one of these subjects revealed double the normal hepatic cholesterol content, a markedly deficient rate of bile acid excretion, and evidence for upregulation of the alternative bile acid pathway. Two male subjects studied had hypertriglyceridemia and premature gallstone disease, and their LDL cholesterol levels were noticeably resistant to 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. One subject also had premature coronary and peripheral vascular disease. Study of the kindred, which is of English and Celtic background, revealed that individuals heterozygous for the mutation are also hyperlipidemic, indicating that this is a codominant disorder.


Related Articles

  • Early and severe neurological features in a Wilson disease patient compound heterozygous for two frameshift mutations. Angius, A.; Dessi, V.; Lovicu, M.; De Virgiliis, S.; Pirastu, M.; Cao, A.; Antonio, C. // European Journal of Pediatrics;1998, Vol. 157 Issue 2, p128 

    Unlabelled: We describe a patient with Wilson disease who presented at 11 years of age with neurological symptoms and subsequent rapid progression of neurological impairment but absent hepatic manifestations. Molecular analysis showed compound heterozygosity for two frameshift...

  • Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. Jones, Christopher; Garuti, Rita; Michaely, Peter; Wei-Ping Li; Maeda, Nobuyo; Cohen, Jonathan C.; Herz, Joachim; Hobbs, Helen H.; Li, Wei-Ping // Journal of Clinical Investigation;Jan2007, Vol. 117 Issue 1, p165 

    Genetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia...

  • Human CYP7A1 deficiency: progress and enigmas. Beigneux, Anne; Hofmann, Alan F.; Young, Stephen G. // Journal of Clinical Investigation;7/1/2002, Vol. 110 Issue 1, p29 

    Discusses the progress and enigmas in human CYP7A1 deficiency. Association between low levels of bile acids synthesis, as in CYP7A1 with hypertriglyceridemia; Qualitative and quantitative effects on bile acids; Differences in CYP7A1-deficient mice and humans.

  • Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. MacArthur, Jennifer M.; Bishop, Joseph R.; Stanford, Kristin I.; Lianchun Wang; Bensadoun, André; Witztum, Joseph L.; Esko, Jeffrey D.; Wang, Lianchun; Bensadoun, André // Journal of Clinical Investigation;Jan2007, Vol. 117 Issue 1, p153 

    We examined the role of hepatic heparan sulfate in triglyceride-rich lipoprotein metabolism by inactivating the biosynthetic gene GlcNAc N-deacetylase/N-sulfotransferase 1 (Ndst1) in hepatocytes using the Cre-loxP system, which resulted in an approximately 50% reduction in sulfation of liver...

  • Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. Li-Hawkins, Jia; Gåfvels, Mats; Olin, Maria; Lund, Erik G; Andersson, Ulla; Schuster, Gertrud; Björkhem, Ingemar; Russell, David W; Eggertsen, Gosta // Journal of Clinical Investigation;10/1/2002, Vol. 110 Issue 7, p1191 

    Cholesterol is converted into dozens of primary and secondary bile acids through pathways subject to negative feedback regulation mediated by the nuclear receptor farnesoid X receptor (FXR) and other effectors. Disruption of the sterol 12alpha-hydroxylase gene (Cyp8b1) in mice prevents the...

  • Mitochondria. Chinnery P F; Schon E A; Chinnery, P F; Schon, E A // Journal of Neurology, Neurosurgery & Psychiatry;Sep2003, Vol. 74 Issue 9, p1188 

    Following the discovery in the early 1960s that mitochondria contain their own DNA (mtDNA), there were two major advances, both in the 1980s: the human mtDNA sequence was published in 1981, and in 1988 the first pathogenic mtDNA mutations were identified. The floodgates were opened, and the...

  • Feeding difficulties in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Lund, A M; Leonard, J V // Archives of Disease in Childhood;Dec2001, Vol. 85 Issue 6, p487 

    Feeding difficulties are common in long chain 3-hydroxyacyl-CoA dehydrogenase deficiency in early childhood and are not associated with developmental disability, metabolic abnormalities, or the overnight feeding regimen. They are an inherent part of the phenotype and it is important to recognise...

  • A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders. Yoshida, K.; Sanada, M.; Kato, M.; Kawahata, R.; Matsubara, A.; Takita, J.; Shih, L.-Y.; Mori, H.; Koeffler, H. P.; Ogawa, S. // Leukemia (08876924);Jan2011, Vol. 25 Issue 1, p184 

    A letter to the editor is presented regarding the mutations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) in a series of cases with myelodysplastic syndrome (MDS).

  • Low-Density Lipoprotein Receptor Gene Mutation Analysis and Structure–Function Correlation in an Omani Arab Family With Familial Hypercholesterolemia. Al-Rasadi, Khalid; Al-Waili, Khalid; Al-Zidi, Ward Al-Muna; Al-Abri, Abdul Rahim; Al-Hinai, Ali T.; Al-Sabti, Hilal Ali; Al-Tobi, Sheikha; Al-Zakwani, Ibrahim; Al-Zadjali, Fahad; Al-Hashmi, Khamis; Banerjee, Yajnavalka // Angiology;Nov2014, Vol. 65 Issue 10, p911 

    Familial hypercholesterolemia (FH) is an autosomal dominant disorder typified by elevated low-density lipoprotein cholesterol (LDL-C) levels caused by mutations in the LDL receptor (LDLR), apolipoprotein B (ApoB), or proprotein convertase subtilisin/kexin type 9 (PCSK9) genes. Previously, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics